Skip to main content

Advertisement

Table 3 Individual control subject characteristics

From: Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles

Subject Data-set Gender Race Medications
19 1 F Caucasian Alphagan OP, Xalatan OP
20 1 F Caucasian _
21 1 F Caucasian Atorvastatin, losartan, atenolol, aspirin, hydrochlorothiazide
22 1 M Caucasian Atorvastatin, glargine, lisinopril, fluoxetine, amlodipine, Systane OP
23 1 F Caucasian Levothyroxine, sertraline
24 1 M Caucasian Diazepam, simvastatin, aspirin
25 1 M Caucasian Ibuprofen
26 1 F Caucasian _
27 1 F Caucasian Sertraline, desogestrel/ethinyl estradiol
28 1 M Caucasian Ibuprofen, diazepam, acetaminophen/aspirin, esomeprazole, sumatriptan
29 1 F Caucasian _
30 1 F Asian Trazodone, sertraline, levonorgestrel/ethinyl, estradiol, atorvastatin, ibuprofen, acetaminophen
31 2 F Caucasian Acetaminophen, ibuprofen
32 2 F Caucasian _
33 2 F Mixed* _
34 2 F Caucasian Ibuprofen
35 2 F Caucasian Etonogestrel/ethinyl estradiol VA
36 2 F Caucasian _
37 2 F Caucasian Etonogestrel/ethinyl estradiol VA, cetirizine
38 2 F Caucasian Desogestrel/ethinyl estradiol
39 2 F Caucasian _
40 2 F Caucasian Estradiol 0.01% cream, levonorgestrel
41 2 M Caucasian _
42 2 F Caucasian Duloxetine, valacyclovir, cyclobenzaprine
43 2 F Caucasian _
  1. *mixed race is seven out of eight Caucasian and one out of eight African-American.